Australia, Oct. 7 -- Definium Therapeutics US Inc., owns the trademark (2661526) for 'NEUPLIXO' till April 17, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, generalized anxiety disorder (gad) and major depressive disorder (mdd).] and 05 [Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations ...